Redmile Group, LLC - 10%+ Owner at ADC Therapeutics SA

Insider Transactions and Holdings

Entity Type: Company
Role: 10%+ Owner
Stock Symbol: ADCT on NYSE
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Redmile Group, LLC - trading volume in the past year for ADC Therapeutics SA

	Shares	%	Avg Price	Total $
Buys	+15.3M	99.8%	$4.68	+$71.5M
Sells	-25.4K	0.2%	$2.07	-$52.5K
Net	+15.2M	99.7%		+$71.5M

Holdings reported by Redmile Group, LLC for ADC Therapeutics SA

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Shares, par value CHF 0.08 per share	15.7M	$59.7M	$3.81	Dec 11, 2024	Indirect
Common Shares, par value CHF 0.08 per share	13.1M	$50.1M	$3.81	Dec 11, 2024	Direct
Common Shares, par value CHF 0.08 per share	15.7M	$44M	$2.81	Jul 1, 2024	Indirect
Common Shares, par value CHF 0.08 per share	13M	$36.5M	$2.81	Jul 1, 2024	Direct
Pre-Funded Warrants	8.16M	$16.9M	$2.07	Dec 4, 2024	Indirect	Common Shares
Pre-Funded Warrants	6.13M	$12.7M	$2.07	Dec 4, 2024	Direct	Common Shares
Cash-settled Swaps	108K	$364K	$3.38	Feb 7, 2024	Direct	Common Shares
Cash-settled Swaps	11.2K	$37.8K	$3.38	Feb 2, 2024	Indirect	Common Shares

Transactions reported by Redmile Group, LLC for ADC Therapeutics SA

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.